Prevalence and Hospitalization Burden of Cytomegalovirus Infection in Solid Organ Transplant Recipients in the United States
Transplant Infectious Disease · 13.08.2026
DOI: 10.1111/tid.70306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, online erschienen am 13.08.2026. Verfasst von Chia-Yu Chiu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, University of Colorado, Aurora, Colorado, USA. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Kamada Pharmaceuticals.
Abstract (Originalsprache)
Introduction
Cytomegalovirus (CMV) is associated with substantial morbidity among solid organ transplant recipients (SOTRs). However, data on the burden of CMV‐associated hospitalization is limited.
Methods
We used data from Scientific Registry of Transplant Recipients and National Readmissions Database, which include hospitalization information for SOTR across the United States, collected between 2016 and 2022. We estimate prevalence of CMV infection among adult SOTR, using two reference populations: (a) all living SOTR, and (b) SOTR with at least one hospitalization. We also describe hospitalization burden among SOTR with versus without CMV infection.
Results
Between 2016 and 2022, an estimated total of 950 420 hospitalized adult SOTR were identified. The average prevalence of hospitalized CMV infection was 144 per 10 000 living SOTR. The average prevalence of CMV infection among hospitalized SOTR was 385 per 10 000 hospitalized recipients. Both were the highest among lung recipients (583 and 993, respectively). Within a 30‐day follow‐up window, recipients with CMV infection had 48% higher hospital days (mean: 14.6 vs. 7.6 days) and 67% higher hospitalization cost (mean: $56 146.6 vs. $27 563.3) than those without CMV infection. These findings were consistently higher across all CMV disease types. There were no significant changes in hospital days or costs over time among recipients with CMV infection.
Conclusion
CMV infection was associated with a consistently high hospitalization burden among SOTR, across all transplant types and CMV disease throughout the study period. Optimizing CMV management strategies is essential to reducing the economic burden in this population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, University of Colorado, Aurora, Colorado, USA.
- Division of Transplant Surgery, Department of Surgery, University of Colorado, Aurora, Colorado, USA.
ORCID-Profile: Rocio Lopez, Jesse D Schold
Förderung
- Kamada Pharmaceuticals
Zitieren
APA
Chiu, C. Y., Lopez, R., Nydam, T., & Schold, J. D. (2026). Prevalence and Hospitalization Burden of Cytomegalovirus Infection in Solid Organ Transplant Recipients in the United States. Transplant Infectious Disease. https://doi.org/10.1111/tid.70306
Vancouver
Chiu CY, Lopez R, Nydam T, Schold JD. Prevalence and Hospitalization Burden of Cytomegalovirus Infection in Solid Organ Transplant Recipients in the United States. Transplant Infectious Disease. 2026. doi:10.1111/tid.70306
BibTeX
@article{Chiu2026,
author = {Chiu, Chia-Yu and Lopez, Rocio and Nydam, Trevor and Schold, Jesse D},
title = {Prevalence and Hospitalization Burden of Cytomegalovirus Infection in Solid Organ Transplant Recipients in the United States},
journal = {Transplant Infectious Disease},
year = {2026},
doi = {10.1111/tid.70306}
}
EUVIMED